Company Receives NIH Grant for Novel Investigational Antibiotic to Combat "Super Gonorrhea"
May 27th 2025TAXIS Pharmaceuticals announced it received a $2.9 million federal grant, which will allow the company to further advance its efforts with its dihydrofolate reductase inhibitors for the rapidly spreading and antibiotic-resistant strain of Neisseria gonorrhoeae.
Clinicians Discuss the State of Vaccines Today
A panel discusses how vaccine policy under new federal government policies, why misinformation has flourished and what individual providers can do to win back patient trust.